Hims & Hers Health, Inc.

HIMS

$30.50

Updated: 22/09/2026, 17:32:54

Market Cap

$6.81B

Sector

Healthcare

Industry

Medical - Care Facilities

Country

Stock valuation chart

One-year closing share-price history for HIMS

Company Profile

Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.

USD

NYSE

CEO: Andrew Dudum

Employees: 2,442

https://www.hims.com

Asset Summaries

Latest generated summaries for HIMS

No summaries found.

Detailed business

Structured knowledge from the latest official annual filing.

No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.

Full company information

Latest profile, trading, valuation, and identifier data stored for HIMS.

Share price: $30.50
Market cap: $6.81B
Exchange: NYSE
Currency: USD
CEO: Andrew Dudum
Employees: 2,442
IPO date: 13/09/2019
Beta: 2.412
Last dividend: $0.00
Day range: $29.28 – $30.81
52-week range: $13.74 – $65.30
1-day performance: 3.92%
1-year performance: 121.98%
Current drawdown (1Y): -53.29%
CIK: 0001773751
CUSIP: 433000106
ISIN: US4330001060
Created: 07/12/2025, 04:32:32
Last update: 22/09/2026, 17:32:54

Track Hims & Hers Health, Inc. with an AI analyst

See which prediction-market events move HIMS, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Create a free account See what the world decides next

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News

News linked to HIMS from your Railway `news_articles` table.

Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today

Zacks Investment Research • STOCK • 10/06/2026, 20:45:34

Hims & Hers Health (HIMS) Up 15.8% Since Last Earnings Report: Can It Continue?

Zacks Investment Research • STOCK • 10/06/2026, 14:31:09

Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know

Zacks Investment Research • STOCK • 08/06/2026, 12:01:27

Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform